* CVRx Inc CVRX.OQ reported a quarterly adjusted loss
of 43
cents per share for the quarter ended December 31, higher than
the same quarter last year, when the company reported EPS of -44
cents. The mean expectation of seven analysts for the quarter
was for a loss of 38 cents per share. Wall Street expected
results to range from -42 cents to -34 cents per share.
* Revenue rose 35.7% to $15.34 million from a year ago;
analysts
expected $15.06 million.
* CVRx Inc's reported EPS for the quarter was a loss of 43
cents.
* The company reported a quarterly loss of $10.65 million.
* CVRx Inc shares had risen by 22.0% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 3.3%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for CVRx Inc is
$20.00
This summary was machine generated from LSEG data February 5 at
01:27 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2024 -0.38 -0.43 Missed
Sep. 30 2024 -0.47 -0.57 Missed
Jun. 30 2024 -0.55 -0.65 Missed
Mar. 31 2024 -0.54 -1.04 Missed